Zheng Pang
250355, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Piezo1-specific deletion in macrophage attenuates radiation-induced lung injury progression in mice.
Piezo1-specific deletion in macrophage attenuates radiation-induced lung injury progression in mice.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: March 07, 2026
Isoliquiritigenin ameliorates Pseudomonas aeruginosa-induced acute lung injury through inhibiting lung epithelial cell ferroptosis via PPARγ/Nrf2/GPX4 axis.
Journal: European journal of pharmacology
Published: January 20, 2026
Advances in electrical stimulation for wound healing.
Journal: Frontiers in bioengineering and biotechnology
Published: July 09, 2025
Luteolin inhibits inflammation and M1 macrophage polarization in the treatment of Pseudomonas aeruginosa-induced acute pneumonia through suppressing EGFR/PI3K/AKT/NF-κB and EGFR/ERK/AP-1 signaling pathways.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 22, 2024
Kaempferol Mitigates Pseudomonas aeruginosa-Induced Acute Lung Inflammation Through Suppressing GSK3β/JNK/c-Jun Signaling Pathway and NF-κB Activation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 13, 2024
Fatty Acids Derived from Royal Jelly Exert Anti-Inflammatory and Antibacterial Activities in the Treatment of Pseudomonas aeruginosa-Induced Acute Pneumonia.
Journal: Journal of medicinal food
Published: November 25, 2024
Quercetin attenuates Pseudomonas aeruginosa-induced acute lung inflammation by inhibiting PI3K/AKT/NF-κB signaling pathway.
Journal: Inflammopharmacology
Published: November 01, 2023
Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
Journal: Journal of ethnopharmacology
Published: April 25, 2023
Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25.
Journal: Microbial cell factories
Published: October 08, 2022
Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives.
Journal: Frontiers in oncology
Published: March 07, 2022
Last Updated: 09/26/2026